<?xml version="1.0" encoding="iso-8859-1" ?>
<rss version="2.0" xmlns:s="http://resources.bnet.com/">
<channel>
	<title><![CDATA[dan weiss Resources | BNET]]></title>
	<link><![CDATA[http://resources.bnet.com/topic/dan+weiss.html]]></link>
	<description><![CDATA[White papers, case studies, business articles, and blog posts relating to dan weiss]]></description>
	<s:counts start="0" returned="4" found="4" />
	<language>en-us</language>
	<item>
		<title><![CDATA[AspenBio: Bursting with Possibilities]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F149647-aspenbio-bursting-with-possibilities%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[Dan Weiss submits:   AspenBio APPY is a Colorado-based biopharmaceutical company focused on the development of a test for appendicitis and for improvements in the area of animal reproduction where the company has formed a partnership with Novartis NVS. Appendicitis is swelling and inflammation of the appendix which typically...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<pubDate>Sun, 19 Jul 2009 05:20:15 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/biotech.html"><![CDATA[Biotech]]></category>
		<category domain="http://resources.bnet.com/topic/dan+weiss.html"><![CDATA[Dan Weiss]]></category>
		<category domain="http://resources.bnet.com/topic/aspenbio+pharma+inc..html"><![CDATA[AspenBio Pharma Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/novartis+ag.html"><![CDATA[Novartis AG]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">APPY</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">NVS</category>
		<category domain="tickers">APPY,NVS</category>
	</item>
	<item>
		<title><![CDATA[A Look at ISTA's Strong Pipeline]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F143645-a-look-at-ista-s-strong-pipeline%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[Dan Weiss submits:   ISTA is a California-based company which has emerged over the past several years to become the fourth largest prescription ophthalmic visual pathway firm in the $5 billion U.S. market. The company currently has three products on the market- by Dan Weiss]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<pubDate>Wed, 17 Jun 2009 02:18:05 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/biotech.html"><![CDATA[Biotech]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/dan+weiss.html"><![CDATA[Dan Weiss]]></category>
		<category domain="http://resources.bnet.com/topic/ista+pharmaceuticals+inc..html"><![CDATA[Ista Pharmaceuticals Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">ISTA</category>
		<category domain="tickers">ISTA</category>
	</item>
	<item>
		<title><![CDATA[Outlook on Sector Performance: More Pain Ahead for Financials]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F117970-outlook-on-sector-performance-more-pain-ahead-for-financials%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[Dan Weiss submits:   In late December, nearly everyone was looking forward to the end of 2008 and the start of a new year and new presidency. January started off with a strong rally and at least for a couple of days, U.S. equities were over 20% above where...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<pubDate>Mon, 02 Feb 2009 08:20:42 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/us+market.html"><![CDATA[US Market]]></category>
		<category domain="http://resources.bnet.com/topic/financial.html"><![CDATA[Financial]]></category>
		<category domain="http://resources.bnet.com/topic/dan+weiss.html"><![CDATA[Dan Weiss]]></category>
	</item>
	<item>
		<title><![CDATA[Calendar Year S&P 500 Returns in Perspective]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F112777-calendar-year-s-p-500-returns-in-perspective%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[Dan Weiss submits:   2008 has been a year that many would like to forget. From a 39%+ decline in the S&P 500 to a nearly 50% fall in the price of crude oil (more than a 70% from highs in July) to declines in the prices of nearly...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<pubDate>Wed, 31 Dec 2008 03:13:28 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/us+market.html"><![CDATA[US Market]]></category>
		<category domain="http://resources.bnet.com/topic/dan+weiss.html"><![CDATA[Dan Weiss]]></category>
	</item>
</channel>
</rss>
